Problematic meta-analyses: Bayesian and frequentist perspectives on combining randomized controlled trials and non-randomized studies
Authors:
Open Access
- 27 April 2024
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-14
Abstract
In the literature, the propriety of the meta-analytic treatment-effect produced by combining randomized controlled trials (RCT) and non-randomized studies (NRS) is questioned, given the inherent confounding in NRS that may bias the meta-analysis. The current study compared an implicitly principled pooled Bayesian meta-analytic treatment-effect with that of frequentist pooling of RCT and NRS to determine how well each approach handled the NRS bias. Binary outcome Critical-Care meta-analyses, reflecting the importance of such outcomes in Critical-Care practice, combining RCT and NRS were identified electronically. Bayesian pooled treatment-effect and 95% credible-intervals (BCrI), posterior model probabilities indicating model plausibility and Bayes-factors (BF) were estimated using an informative heavy-tailed heterogeneity prior (half-Cauchy). Preference for pooling of RCT and NRS was indicated for Bayes-factors > 3 or < 0.333 for the converse. All pooled frequentist treatment-effects and 95% confidence intervals (FCI) were re-estimated using the popular DerSimonian-Laird (DSL) random effects model. Fifty meta-analyses were identified (2009–2021), reporting pooled estimates in 44; 29 were pharmaceutical-therapeutic and 21 were non-pharmaceutical therapeutic. Re-computed pooled DSL FCI excluded the null (OR or RR = 1) in 86% (43/50). In 18 meta-analyses there was an agreement between FCI and BCrI in excluding the null. In 23 meta-analyses where FCI excluded the null, BCrI embraced the null. BF supported a pooled model in 27 meta-analyses and separate models in 4. The highest density of the posterior model probabilities for 0.333 < Bayes factor < 1 was 0.8. In the current meta-analytic cohort, an integrated and multifaceted Bayesian approach gave support to including NRS in a pooled-estimate model. Conversely, caution should attend the reporting of naïve frequentist pooled, RCT and NRS, meta-analytic treatment effects.Keywords
This publication has 127 references indexed in Scilit:
- Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high‐risk populations: A systematic review and meta‐analysisHealth Science Reports, 2021
- Clinical Sequelae From Overfeeding in Enterally Fed Critically Ill Adults: Where Is the Evidence?Journal of Parenteral and Enteral Nutrition, 2019
- Contribution to the discussion of “When should meta‐analysis avoid making hidden normality assumptions?” A Bayesian perspectiveBiometrical Journal, 2018
- When should meta‐analysis avoid making hidden normality assumptions?Biometrical Journal, 2018
- Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trialsCochrane Database of Systematic Reviews, 2014
- Checklists of methodological issues for review authors to consider when including non‐randomized studies in systematic reviewsResearch Synthesis Methods, 2013
- An introduction to methodological issues when including non‐randomised studies in systematic reviews on the effects of interventionsResearch Synthesis Methods, 2013
- Issues relating to confounding and meta‐analysis when including non‐randomized studies in systematic reviews on the effects of interventionsResearch Synthesis Methods, 2012
- Issues relating to study design and risk of bias when including non‐randomized studies in systematic reviews on the effects of interventionsResearch Synthesis Methods, 2012
- Grouped random effects models for Bayesian meta-analysisStatistics in Medicine, 1997